A new U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Pejman Mohammadi and Dr. Abraham Palmer.
The grant is titled “Deep Analysis of Transcriptome to Understand the Genetics of Substance Use Disorders in Rats” (U01DA060443) and it will start July 1, 2025 and end on March 31, 2030.
A new R21 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Marsida Kallupi, with Dr. Abraham Palmer as co-investigator.
The 2-year grant is titled “Enhancing Addiction Severity Prediction by Modulating GABAergic Activity in the Central Amygdala of RATTACA Rats” and it will start July 15, 2025 and end on June 30, 2027.
Congratulations!
Our recently-funded NIDA P30 Center grant was announced in an article for the campus publication UC San Diego Today. The article is titled “UC San Diego Awarded $8 Million to Uncover Genetic Foundations of Substance Use Disorders,” published on October 28, 2024.
Congratulations to the 2024 Pilot Grants recipients:
Olivier George, PhD (University California – San Diego).
Project: Role of Ces1 genes in cocaine metabolism and SUD.
Samantha Ayoub, PhD (University California – San Diego).
Project: Testing the impact of acute, chronic, and withdrawal of THC & CBD on sensorimotor gating in HS rats.
Marsida Kallupi, PhD (University California – San Diego).
Project: Investigating Synaptic Mechanisms of Addiction Vulnerability Using RATTACA Rats
The 100th generation of HS rats have begun to be born on Nov 8, 2023